Jian, C., Bing, H., Xinmin, L. et al. Experimental study on effect of folium ginkgo biloba in treating pulmonary interstitial fibrosis in rats., CJIM 6, 232 (2000). https://doi.org/10.1007/BF02950942
Jian CHEN, Bing HE, Xinmin LIU, et al. Experimental study on effect of folium ginkgo biloba in treating pulmonary interstitial fibrosis in rats. [J]. Chinese Journal of Integrative Medicine 6(3):232(2000)
Jian, C., Bing, H., Xinmin, L. et al. Experimental study on effect of folium ginkgo biloba in treating pulmonary interstitial fibrosis in rats., CJIM 6, 232 (2000). https://doi.org/10.1007/BF02950942DOI:
Jian CHEN, Bing HE, Xinmin LIU, et al. Experimental study on effect of folium ginkgo biloba in treating pulmonary interstitial fibrosis in rats. [J]. Chinese Journal of Integrative Medicine 6(3):232(2000) DOI: 10.1007/BF02950942.
Experimental study on effect of folium ginkgo biloba in treating pulmonary interstitial fibrosis in rats
摘要
Objective: To evaluate the therapeutic effect and mechanism of folium Ginkgo biloba (FGB) in treating pulmonary interstitial fibrosis (PIF) induced by bleomycin in rats.Methods: PIF models of bleomycin-A5-induced pulmonary fibrosis were established in rats
they were treated by Bailuda
a preparation of FGB
and the pathological changes
collagen protein level
nuclear factor kB(NF-kB) activity
transforming growth factor β (TGF-β) mRNA expression and protein level of the lung tissue were measured.Results: In the Bailuda treated group after treatment
amelioration of the pulmonary alveolitis and fibrosis were shown in pathological section (P < 0.05) and collagen protein content was lesser (P<0.01) as compared with those in the model control group. After 1 week of Bailuda treatment
the NF-kB activity of pulmonary alveola macrophage lowered by 47. 3 %
and levels of TGF-β mRNA expression and protein were all decreased (P < 0.05).Conclusions: Bailuda has definite effect in treating PIF. The mechanism may be through inhibiting the activity of NF-kB
decreasing TGF-β mRNA expression and protein
so as to ameliorate the inflammation and fibrosis.
Abstract
Objective: To evaluate the therapeutic effect and mechanism of folium Ginkgo biloba (FGB) in treating pulmonary interstitial fibrosis (PIF) induced by bleomycin in rats.Methods: PIF models of bleomycin-A5-induced pulmonary fibrosis were established in rats
they were treated by Bailuda
a preparation of FGB
and the pathological changes
collagen protein level
nuclear factor kB(NF-kB) activity
transforming growth factor β (TGF-β) mRNA expression and protein level of the lung tissue were measured.Results: In the Bailuda treated group after treatment
amelioration of the pulmonary alveolitis and fibrosis were shown in pathological section (P < 0.05) and collagen protein content was lesser (P<0.01) as compared with those in the model control group. After 1 week of Bailuda treatment
the NF-kB activity of pulmonary alveola macrophage lowered by 47. 3 %
and levels of TGF-β mRNA expression and protein were all decreased (P < 0.05).Conclusions: Bailuda has definite effect in treating PIF. The mechanism may be through inhibiting the activity of NF-kB
decreasing TGF-β mRNA expression and protein
so as to ameliorate the inflammation and fibrosis.
关键词
BleomycinFebrile ConvulsionPathological SectionModel Control GroupTongue Coating
Keywords
BleomycinFebrile ConvulsionPathological SectionModel Control GroupTongue Coating